# Caribou Biosciences (CRBU) — Overview

CRBU · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/crbu

## Price

Last close $0.46 on Oct 15, 2026. 52-week range $0.46 – $2.84.

## Company profile

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $10.0M |
| Revenue (quarter) | $1.5M |
| Revenue growth (year over year) | -43.79% |
| Gross profit (trailing twelve months) | $10.0M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$103.4M |
| Net income (quarter) | −$24.3M |
| Net income growth (year over year) | 55.11% |
| Net margin | -1030.42% |
| Return on equity | -78.27% |
| EPS (trailing twelve months) | −$1.08 |
| Book value per share | $0.93 |
| P/E (trailing twelve months) | — |
| Price to book | 0.5 |
| Debt to assets | 31.29% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Caribou Biosciences (CRBU) profitable?

No. Caribou Biosciences reported a net loss of $103.4M over the trailing twelve months.

### How much revenue does Caribou Biosciences (CRBU) make?

Caribou Biosciences generated $10.0M in revenue over the trailing twelve months, down 43.79% year over year.

### How do I buy stock in Caribou Biosciences (CRBU)?

CRBU trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).